Feed Insights Top Reports Pricing

⌘K

09:36:12·644d

NEWSReleasevia Quantisnow

2U Shares Halted; Stock Currently Down -69.42%

ByQuantisnow·Wall Street's wire, on your screen.

Technology

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TWOU (2U Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

TWOU
2U Inc.
Technology

Recent analyst ratings

Feb 13UpdateNeedham-
Nov 10UpdateBarrington Research-
Nov 10UpdateCantor Fitzgerald$1.50
Aug 9UpdateRobert W. Baird$4.00
Apr 27UpdateCantor Fitzgerald$7.40
Nov 22UpdateCredit Suisse$8.00

Related

SEC629d
SEC Form 10-Q filed by 2U Inc.
SEC637d
2U Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
NEWS644d
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
NEWS644d
2U Shares Resume Trading
NEWS644d
2U Shares Resume
SEC644d
2U Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure
NEWS644d
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
NEWS645d
2U Announces Strategic Agreement With Debtholders To Eliminate Half Of Debt And Infuse $110M In New Capital

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022